GlassScriptPhysician profile
Ashley R Meadows
NPI 1700539418
$4,742.52
in general payments reported to CMS, 2019-2025
27 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $702 · 2023: $1,310 · 2024: $1,403 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,014 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,013.66 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,573.30 | 2022-2025 | |
| Alkermes, INC. | $539.98 | 2022-2025 | Aristada, Lybalvi, Aristada Initio |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $495.78 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $390.08 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $267.27 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $249.67 | 2022-2023 | Uzedy |
| Janssen Pharmaceuticals, INC | $161.14 | 2024-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Lundbeck LLC | $152.80 | 2022-2024 | Rexulti, Abilify Maintena |
| Exact Sciences Corporation | $137.07 | 2024-2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $92.82 | 2025 | Fanapt |
| Boston Scientific Corporation | $88.11 | 2023 | Wavewriter Alpha Prime 16 |
| Novo Nordisk INC | $84.41 | 2024-2025 | Rybelsus, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $75.49 | 2022-2025 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $75.13 | 2024-2025 | Cobenfy |
| Corium, LLC | $65.27 | 2024-2025 | Azstarys |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $55.72 | 2024-2025 | |
| Abiomed | $46.88 | 2024-2025 | Impella |
| Lilly USA, LLC | $31.97 | 2024-2025 | Zepbound |
| Amgen INC. | $22.08 | 2024 | Repatha |
| Tandem Diabetes Care, INC. | $21.05 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Esperion Therapeutics, INC. | $20.46 | 2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $18.50 | 2025 | |
| Tonix Medicines, INC. | $18.01 | 2025 | Tonmya |
| Inspire Medical Systems, INC. | $16.97 | 2025 | Inspire |
| Antares Pharma, INC. | $15.34 | 2024 | Xyosted |
| Medtronic, INC. | $14.10 | 2024 | Minimed 780g |
| Supernus Pharmaceuticals, INC. | $13.12 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.